Wells Fargo analyst Steven Chercover downgrades Signature Bank (NASDAQ:SBNY)
Jefferies Maintains Buy on Provention Bio, Raises Price Target to $15
Jefferies analyst Chris Howerton maintains Provention Bio (NASDAQ:PRVB) with a Buy and raises the price target from $10 to $15.